CDR2 Antikörper (AA 1-454) (Biotin)
Kurzübersicht für CDR2 Antikörper (AA 1-454) (Biotin) (ABIN7147485)
Target
Alle CDR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-454
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Cerebellar degeneration-related protein 2 protein (1-454AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
-
Andere Bezeichnung
- CDR2
-
Hintergrund
-
Background: Antibody-associated paraneoplastic cerebellar degeneration (the Yo syndrome) is an uncommon disorder in which an immune response is specifically directed against tumor tissue and the cerebellum.
Aliases: AA617262 antibody, CDR 2 antibody, CDR 62 antibody, CDR2 antibody, CDR2_HUMAN antibody, CDR62 antibody, Cerebellar degeneration related protein 2 62 kDa antibody, Cerebellar degeneration related protein 2 antibody, Cerebellar degeneration related protein antibody, Cerebellar degeneration-related protein 2 antibody, Major Yo paraneoplastic antigen antibody, MGC116181 antibody, MGC144810 antibody, MGC144811 antibody, Paraneoplastic cerebellar degeneration associated antigen antibody, Paraneoplastic cerebellar degeneration-associated antigen antibody, PCD 17 antibody, PCD17 antibody, RGD1310578 antibody, Yo antibody, Yo paraneoplastic antigen antibody
-
UniProt
- Q01850
Target
-